1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Ectodermal Dysplasia 1, Anhidrotic: new trials by email Literature Review of Ectodermal Dysplasia 1, Anhidrotic trials Research Report on Ectodermal Dysplasia 1, Anhidrotic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia ER004 - X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) | Phase 2 | Recruiting | EspeRare Foundation | 20 | 2022-04-26 | 2025-04-30 |
| Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) EDI200 - X-Linked Hypohidrotic Ectodermal Dysplasia | Phase 2 | Completed | Edimer Pharmaceuticals | 6 | 2013-04-01 | 2016-01-20 |
Abnormalities, Multiple (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Ectodermal Dysplasia (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Skin Abnormalities (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2)
Fc-EDA (1)
Edimer Pharmaceuticals (1) · EspeRare Foundation (1)
France (2) · Germany (2) · Italy (2) · United Kingdom (2) · United States (2) · Spain (1)
Holm Schneider, MD (1) · Kenneth Huttner, MD, PhD (1)